DexCom, Inc. - Common Stock (NQ:DXCM)

84.09 -0.20 (-0.24%)

Delayed Quote Updated: 2:34 PM EDT, Oct 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

51 52 Next >

Dexcom Reports First Quarter 2026 Financial Results

April 30, 2026

From DexCom, Inc.

Via Business Wire

2026 Market Cap Madness Championship: Loren v. Emily ↗

April 29, 2026

It’s time to crown a winner: defending champion Emily Flippen faces off against Cinderella challenger Loren Horst in the Market Cap Madness World Championship.

Via The Motley Fool

DexCom (DXCM) Q1 Earnings: What To Expect

April 28, 2026

Medical device company DexCom (NASDAQ:DXCM) will be reporting earnings this Thursday after market close. Here’s what investors should know. DexCom beat analy...

Via StockStory

Topics Artificial Intelligence

DEXCOM INC (NASDAQ:DXCM) Shows Strong Fundamentals and a Promising Technical Breakout Setup ↗

April 24, 2026

Via Chartmill

DexCom Inc (NASDAQ:DXCM) Presents a Growth Stock Breakout Opportunity ↗

March 25, 2026

Via Chartmill

1 Cash-Producing Stock to Target This Week and 2 Facing Challenges

April 24, 2026

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

Via StockStory

Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins ↗

April 23, 2026

Drugmakers won't be the only ones cashing in on the rising popularity of weight loss medicines.

Via The Motley Fool

Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom ↗

April 20, 2026

They offer investors very different value propositions.

Via The Motley Fool

2 Healthcare Stocks That Could Outperform the Market Over the Next Decade ↗

April 16, 2026

Both have helped transform their respective industries.

Via The Motley Fool

3 Reasons Investors Love DexCom (DXCM)

April 16, 2026

Over the last six months, DexCom’s shares have sunk to $62.07, producing a disappointing 6.4% loss - a stark contrast to the S&P 500’s 5.1% gain. This may ha...

Via StockStory

Topics Stocks

Explore the top gainers and losers within the S&P500 index in today's session. ↗

April 13, 2026

Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.

Via Chartmill

Q4 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks

April 12, 2026

Let’s dig into the relative performance of DexCom (NASDAQ:DXCM) and its peers as we unravel the now-completed Q4 patient monitoring earnings season. Patient ...

Via StockStory

Topics Artificial Intelligence

DexCom Inc (NASDAQ:DXCM) Fits the Affordable Growth Investment Strategy ↗

April 10, 2026

DexCom (DXCM) exemplifies GARP investing, offering strong growth in glucose monitoring at a price reasonable relative to its industry and supported by robust profitability.

Via Chartmill

DexCom (DXCM) Q2 2025 Earnings Call Transcript ↗

April 08, 2026

DexCom (DXCM) Q2 2025 Earnings Call Transcript

Via The Motley Fool

Topics Artificial Intelligence Earnings

DexCom (DXCM) Q3 2025 Earnings Call Transcript ↗

April 08, 2026

DexCom (DXCM) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Eli Lilly Secures Landmark FDA Approval for Oral Weight-Loss Pill, Sending Shares Soaring

April 02, 2026

Shares of Eli Lilly and Company (NYSE: LLY) surged 3.8% on Wednesday following the milestone FDA approval of Foundayo (orforglipron), the first once-daily oral weight-loss pill that does not require...

Via MarketMinute

Topics Economy

Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time

April 02, 2026

From DexCom, Inc.

Via Business Wire

The Medtronic Transformation: A Deep Dive into the Future of a MedTech Titan

April 01, 2026

As of April 1, 2026, the global medical technology landscape is undergoing a profound shift, and at the center of this evolution is Medtronic plc (NYSE: MDT). Long regarded as the "sleeping giant" of...

Via Finterra

Topics Artificial Intelligence Economy Initial Public Offering

2 Growth Stocks with All-Star Potential and 1 That Underwhelm

April 01, 2026

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived thr...

Via StockStory

Topics Artificial Intelligence

Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know

March 27, 2026

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...

Via StockStory

Topics Artificial Intelligence Government Stocks

Stay informed with the top movers within the S&P500 index on Friday. ↗

March 27, 2026

Via Chartmill

These S&P500 stocks are gapping in today's session ↗

March 27, 2026

Via Chartmill

2 of Wall Street’s Favorite Stocks with Solid Fundamentals and 1 Facing Headwinds

March 27, 2026

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...

Via StockStory

2 Healthcare Stocks to Target This Week and 1 That Underwhelm

March 23, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advanceme...

Via StockStory

Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know

March 16, 2026

What Happened? A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries. ...

Via StockStory

Topics Economy Stocks

This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment ↗

March 15, 2026

EyePoint develops sustained-release treatments for retinal diseases, leveraging proprietary technology and strategic industry partnerships.

Via The Motley Fool

This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement ↗

March 15, 2026

This medical technology firm delivers advanced noninvasive monitoring and automation solutions to healthcare providers worldwide.

Via The Motley Fool

Topics Regulatory Compliance

This Internet Infrastructure Stock Plunged 72% in a Year, so Why Did an Investor Buy Up $12 Million? ↗

March 15, 2026

Cogent Communications delivers high-speed internet and data center services to commercial clients across multiple continents.

Via The Motley Fool

Topics Regulatory Compliance

Sotera Health Shares Rise 18% in a Year. Here's What a $37 Million Stake Trim Signals ↗

March 15, 2026

Sotera Health delivers sterilization and lab testing services to regulated industries worldwide, supporting critical supply chains.

Via The Motley Fool

Topics Regulatory Compliance

Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026

March 11, 2026

From DexCom, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

51 52 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.